Delhi High Court denies Novo Nordisk’s interim injunction in the Semaglutide patent suit, allowing Dr. Reddy’s to manufacture and export to non-patented markets.
Get Exclusive access to members only content by email
Subscribe to Lawstreet Journal and Get 10% Off to become Cyber Lawyer Crime Investigator.
![Delhi HC Rejects Interim Injunction To Novo Nordisk in Semaglutide Patent Case Against Dr. Reddy’s [Read Judgment]](/secure/uploads/2025/12/lj_2389_Delhi_HC_Rejects_Interim.webp)
